SJS Investment Consulting’s Bio-Rad Laboratories Class A BIO Stock Holding History

SJS Investment Consulting’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.1K	Buy	65 +62	+2,067%	+$17.6K	﹤0.01%	817
2026 Q1	$837	Buy	3 +1	+50%	+$288	﹤0.01%	1549
2025 Q4	$606	Hold	2	–	–	﹤0.01%	1458
2025 Q3	$561	Hold	2	–	–	﹤0.01%	1194
2025 Q2	$483	Sell	2 -4	-67%	-$946	﹤0.01%	1124
2025 Q1	$1.46K	Sell	6 -2	-25%	-$602	﹤0.01%	858
2024 Q4	$2.63K	Buy	8 +5	+167%	+$1.7K	﹤0.01%	596
2024 Q3	$1K	Hold	3	–	–	﹤0.01%	1068
2024 Q2	$820	Hold	3	–	–	﹤0.01%	1107
2024 Q1	$1.04K	Hold	3	–	–	﹤0.01%	1020
2023 Q4	$969	Sell	3 -1	-25%	-$313	﹤0.01%	972
2023 Q3	$1.43K	Hold	4	–	–	﹤0.01%	774
2023 Q2	$1.52K	Sell	4 -1	-20%	-$407	﹤0.01%	718
2023 Q1	$2.4K	Buy	5 +2	+67%	+$936	﹤0.01%	543
2022 Q4	$1.26K	Buy	3 +1	+50%	+$404	﹤0.01%	836
2022 Q3	$0	Buy	+2	New	+$997	﹤0.01%	1069

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SJS Investment Consulting's BIO Position: Q2 2026 in Review

SJS Investment Consulting increased its Bio-Rad Laboratories Class A (BIO) stake by 2,067% in Q2 2026, buying an estimated $17.6K and bringing the position to 65 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #817.

SJS Investment Consulting first reported a position in BIO in Q3 2022 and has held it in 16 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

SJS Investment Consulting held 65 shares of Bio-Rad Laboratories Class A worth $19.1K as of Q2 2026.
SJS Investment Consulting bought 62 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $17.6K.
Bio-Rad Laboratories Class A made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #817 holding.
SJS Investment Consulting first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and has held it in 16 quarters since.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.